A detailed history of Wolverine Trading, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 52,100 shares of FULC stock, worth $226,634. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,100
Previous 38,000 37.11%
Holding current value
$226,634
Previous $235,000 21.28%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$6.7 - $12.0 $65,874 - $117,984
9,832 Added 71.52%
23,579 $222,000
Q4 2023

Feb 14, 2024

BUY
$3.18 - $6.86 $43,715 - $94,304
13,747 New
13,747 $92,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $226M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.